These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7393746)

  • 1. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinogen degradatiopnroducts in the serum and urine in chronic nephritis].
    Kutyrina IM; Muzychenko LI; Nevraeva OG; Kriachko AA; Tareeva IE
    Sov Med; 1978 Oct; (10):68-75. PubMed ID: 715539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protein supply in healthy subjects and subjects with kidney diseases].
    Gerhardt W
    Z Arztl Fortbild (Jena); 1969 Mar; 63(6):317-22. PubMed ID: 5784072
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acid-base metabolism in kdney diseases].
    Kaufmann W; Ilg R
    Dtsch Med Wochenschr; 1968 Dec; 93(52):2520-5. PubMed ID: 5722754
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the problem of uremic osteopathy. Intestinal calcium absorption disorders in relation to kidney function].
    Schaefer K; Schaefer P; Koeppe P; Opitz A; Höffler D
    Dtsch Med Wochenschr; 1968 May; 93(20):1018-22. PubMed ID: 5648078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical importance of the radioimmunologic determination of beta 2-microglobulin in patients with kidney pathology].
    Trusov VV; Filimonov MA; Kazakova IA; Marizin SA
    Ter Arkh; 1988; 60(11):117-20. PubMed ID: 2907187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current state of the problem of lipid metabolism in patients with kidney diseases].
    Storozhenko AA
    Klin Med (Mosk); 1973 Oct; 51(10):28-30. PubMed ID: 4787276
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunoenzyme determination of fibrinogen and its degradation products in kidney diseases].
    Maĭdannik VG
    Vrach Delo; 1989 May; (5):75-7. PubMed ID: 2672585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of zinc in renal diseases.
    Alam SM; Gupta A; Kumar S; Sikka KK; Srivastava DK
    J Indian Med Assoc; 1986 Aug; 84(8):233-6. PubMed ID: 3559228
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal fibrin stabilization in renal failure.
    Losowsky MS; Walls WD
    Thromb Diath Haemorrh; 1969 Nov; 22(2):216-22. PubMed ID: 5380945
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrin (ogen) Split products of nephropathies].
    Anger H
    Urologe A; 1975 Jan; 14(1):20-4. PubMed ID: 234643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of blood and urinary FDP fragments in patients with renal disease].
    Taura K
    Nihon Jinzo Gakkai Shi; 1983 Mar; 25(3):245-56. PubMed ID: 6887631
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of coagulation in renal disease.
    MacDonald MK; Clarkson AR; Davison AM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):809-28. PubMed ID: 4807810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.